A concurrent audit of high digoxin plasma levels

scientific article

A concurrent audit of high digoxin plasma levels is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/CLPT.1994.37
P698PubMed publication ID8143400

P2093author name stringAtkinson AJ Jr
Piergies AA
Worwag EM
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectdigoxinQ422222
P304page(s)353-358
P577publication date1994-03-01
P1433published inClinical Pharmacology & TherapeuticsQ1101529
P1476titleA concurrent audit of high digoxin plasma levels
P478volume55

Reverse relations

cites work (P2860)
Q42539916A case series of hospitalized patients with elevated digoxin levels
Q36922225A composite screening tool for medication reviews of outpatients: general issues with specific examples
Q79830187Developing a model to determine the effects of adverse drug events in hospital inpatients
Q35844071Development of a computerised decisions support system for renal risk drugs targeting primary healthcare
Q88112782Digoxin Toxicity : Evaluation in Clinical Practice with Pharmacokinetic Correlations
Q73310453Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?
Q40902529Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity
Q46261836Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug
Q47803536Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P-glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers
Q37811970In Vivo Probes of Drug Transport: Commonly Used Probe Drugs to Assess Function of Intestinal P-glycoprotein (ABCB1) in Humans
Q41169214The challenge of in-hospital medication use: an opportunity for clinical pharmacology

Search more.